Malignant Brain Tumor: Clinical Trials

5 trials for Malignant Brain Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 recruiting. 5 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 15Completed 4, Recruiting 1
Phase 21Completed 1

Follow Malignant Brain Tumor: new trials by email Literature Review of Malignant Brain Tumor trials Research Report on Malignant Brain Tumor

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety Study of the Repeated Opening of the Blood-brain Barrier With the SonoCloud® Device to Treat Malignant Brain Tumors in Pediatric Patients
SonoCloud® (9 transducers) - Malignant Brain Tumor, Malignant Glioma
Phase 1RecruitingAssistance Publique - Hôpitaux de Paris242023-02-062026-05-06
Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain Tumors
Magrolimab - Brain Cancer, Malignant Brain Tumor
Phase 1CompletedUniversity of California, San Francisco132022-04-222025-07-09
Study of the IDO Pathway Inhibitor, Indoximod, and Temozolomide for Pediatric Patients With Progressive Primary Malignant Brain Tumors
Indoximod, Temozolomide, Conformal Radiation - Glioblastoma Multiforme, Glioma
Phase 1CompletedNewLink Genetics Corporation812015-10-012020-06-04
Study of IDO Inhibitor and Temozolomide for Adult Patients With Primary Malignant Brain Tumors
Indoximod, Temozolomide, Bevacizumab - Glioblastoma Multiforme, Glioma
Phase 1 / Phase 2CompletedNewLink Genetics Corporation1602014-03-012024-03-27
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
Tarceva (Erlotinib Hydrochloride) - Malignant Brain Tumor, Brain Stem Glioma,
Phase 1CompletedGustave Roussy, Cancer Campus, Grand Paris482005-06-012009-08-07

Narrower conditions

Brain Neoplasms (5)  ·  Glioma (3)  ·  Glioblastoma (2)  ·  Gliosarcoma (2)  ·  Diffuse Intrinsic Pontine Glioma (1)  ·  Ependymoma (1)  ·  Medulloblastoma (1)  ·  Neoplasms, Germ Cell and Embryonal (1)

Broader conditions

Brain Diseases (5)  ·  Central Nervous System Diseases (5)  ·  Central Nervous System Neoplasms (5)  ·  Neoplasms (5)  ·  Neoplasms by Site (5)  ·  Nervous System Diseases (5)  ·  Nervous System Neoplasms (5)  ·  Neoplasms by Histologic Type (3)  ·  Neoplasms, Glandular and Epithelial (3)  ·  Neoplasms, Nerve Tissue (3)  ·  Neoplasms, Neuroepithelial (3)  ·  Neuroectodermal Tumors (3)  ·  Astrocytoma (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Brain Stem Neoplasms (1)

Interventions

1-methyltryptophan (2)  ·  Temozolomide (2)  ·  Bevacizumab (1)  ·  Cyclophosphamide (1)  ·  Erlotinib Hydrochloride (1)  ·  Etoposide (1)  ·  Radiosurgery (1)  ·  Spermine Synthase (1)  ·  magrolimab (1)

Sponsors

NewLink Genetics Corporation (2)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Gustave Roussy, Cancer Campus, Grand Paris (1)  ·  University of California, San Francisco (1)

Countries

United States (3)  ·  France (2)

Top investigators

Gene Kennedy, MD (1)  ·  Howard Colman, MD PhD FAAN (1)  ·  Nicholas Whipple, MD, MPH (1)  ·  Sabine Mueller, MD, PhD (1)  ·  Samuel Cheshier, MD, PhD (1)  ·  Vassal Gilles, Pr. (1)

Results publications

PMID 21653689, PMID 37715730